SCHEMBL6364102

SCHEMBL6364102

C=CCn1c(/C=C/C(=O)OCC)cc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
ALDH1A1 P00352 5/20 0.43
NOD2 Q9HC29 1/20 0.42
NOD1 Q9Y239 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 4/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TTR P02766 1/20 0.40
DPP4 P27487 1/20 0.40
MAPT P10636 2/20 0.40
CYP3A4 P08684 2/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364105 1.00 LMNA (0.45) LMNAALDH1A1NOD2NOD1MEN1
SCHEMBL12355545 0.84 MEN1 (0.48) ALDH1A1NOD2NOD1MEN1KMT2A
SCHEMBL6368595 0.84 KDM4E (0.39) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL6368592 0.84 KDM4E (0.39) LMNAALDH1A1MEN1KMT2AKDM4E
SCHEMBL6369104 0.82 MAPK1 (0.45) LMNAALDH1A1KDM4E
SCHEMBL7135262 0.81 TTR (0.45) NOD2NOD1MEN1KMT2AKDM4E
SCHEMBL7135266 0.81 TTR (0.45) NOD2NOD1MEN1KMT2AKDM4E
SCHEMBL2239999 0.80 KDM4E (0.42) LMNAALDH1A1NOD2NOD1MEN1
SCHEMBL13448721 0.79 OXER1 (0.42) NOD2NOD1MEN1KMT2AKDM4E
SCHEMBL19930278 0.78 NOD2 (0.38) NOD2NOD1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070591-A1 Indole derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-03-31 US disclosed
EP-1464645-A1 INDOLE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070591-A1 Indole derivative TPH1, IDO1, RBX1 LMNA 4014/4885ALDH1A1 1318/4885NOD2 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.